Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Divalproex Sodium in the Treatment of the Cutaneous Manifestations of Scleroderma

NCT02166229 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT02166229
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02166229 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Divalproex Sodium in the Treatment of the Cutaneous Manifestations of Scleroderma
Lead sponsor
Yale University
Phase
Phase 1/2
Overall status
Withdrawn
Start date
June 30, 2014
Completion date
August 31, 2014
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

scleroderma, systemic sclerosis